A Three-Period, Three-Treatment, Six-Sequence Randomized Crossover Study of the Bioavailability and Pharmacokinetics of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers.

Trial Profile

A Three-Period, Three-Treatment, Six-Sequence Randomized Crossover Study of the Bioavailability and Pharmacokinetics of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Mar 2016

At a glance

  • Drugs Diazepam; Diazepam
  • Indications Epilepsy
  • Focus Pharmacokinetics
  • Most Recent Events

    • 07 Feb 2012 Status changed from active, no longer recruiting to completed.
    • 02 Dec 2011 Primary endpoint 'Drug-bioavailability' has been met.
    • 02 Dec 2011 Results presented at the 65th Annual Meeting of the American Epilepsy Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top